Decreased expression of catalase mRNA in thyroid anaplastic carcinoma

被引:20
|
作者
Hasegawa, Y
Takano, T
Miyauchi, A
Matsuzuka, F
Yoshida, H
Kuma, K
Amino, N
机构
[1] Osaka Univ, Grad Sch Med, Dept Lab Med, Suita, Osaka 5650871, Japan
[2] Kuma Hosp, Kobe, Hyogo, Japan
关键词
catalase; superoxide dismutase; mRNA; thyroid; anaplastic carcinoma; MANGANESE SUPEROXIDE-DISMUTASE; MESSENGER-RNA; ANTIOXIDANT DEFENSE; CDNA; MECHANISM; SEQUENCE; TUMORS; CELLS;
D O I
10.1093/jjco/hyg009
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: A decreased expression of glutathione peroxidase mRNA, an antioxidant enzyme, was previously observed in thyroid anaplastic carcinomas. Methods: To clarify the expression of anti oxidant-related enzymes in thyroid anaplastic carcinomas, the expression levels of catalase, copper and zinc superoxide dismutase and manganese superoxide dismutase mRNA in 85 benign and malignant thyroid tissues were measured by means of real-time quantitative reverse transcription-polymerase chain reaction. Results: Decreased expression levels of catalase and copper and zinc superoxide dismutase mRNAs, but not manganese mRNA, were observed in five anaplastic carcinomas compared with normal thyroid tissues and differentiated tumors. Conclusion: These results suggest the possibility that anaplastic carcinoma cells are more likely to suffer damage by oxygen free radicals than normal thyroid cells or differentiated tumor cells.
引用
收藏
页码:6 / 9
页数:4
相关论文
共 50 条
  • [41] Sarcomatoid carcinoma of the thyroid: Report of a subtype of anaplastic thyroid carcinoma
    Huang, Yi-Yin
    Wu, Yung-Kang
    TZU CHI MEDICAL JOURNAL, 2012, 24 (04): : 209 - 211
  • [42] Carcinoma erysipeloides associated with anaplastic thyroid carcinoma
    Lee, SY
    Chang, SE
    Bae, GY
    Choi, JH
    Sung, KJ
    Moon, KC
    Koh, JK
    CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2001, 26 (08) : 671 - 673
  • [43] Decreased relative expression level of trefoil factor 3 mRNA to galectin-3 mRNA distinguishes thyroid follicular carcinoma from adenoma
    Takano, T
    Miyauchi, A
    Yoshida, H
    Kuma, K
    Amino, N
    CANCER LETTERS, 2005, 219 (01) : 91 - 96
  • [44] Anaplastic Thyroid Carcinoma, Version 2.2015
    Haddad, Robert I.
    Lydiatt, William M.
    Ball, Douglas W.
    Busaidy, Naifa Lamki
    Byrd, David
    Callender, Glenda
    Dickson, Paxton
    Duh, Quan-Yang
    Ehya, Hormoz
    Haymart, Megan
    Hoh, Carl
    Hunt, Jason P.
    Iagaru, Andrei
    Kandeel, Fouad
    Kopp, Peter
    Lamonica, Dominick M.
    McCaffrey, Judith C.
    Moley, Jeffrey F.
    Parks, Lee
    Raeburn, Christopher D.
    Ridge, John A.
    Ringel, Matthew D.
    Scheri, Randall P.
    Shah, Jatin P.
    Smallridge, Robert C.
    Sturgeon, Cord
    Wang, Thomas N.
    Wirth, Lori J.
    Hoffmann, Karin G.
    Hughes, Miranda
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2015, 13 (09): : 1140 - 1150
  • [45] Anaplastic Thyroid Carcinoma with Cutaneous Extension
    Kumar, P.
    Thukuntla, S.
    Eskew, J.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2012, 97 (05): : 1414 - 1415
  • [46] Approach to the Patient with Anaplastic Thyroid Carcinoma
    Smallridge, Robert C.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2012, 97 (08): : 2566 - 2572
  • [47] Current status of anaplastic thyroid carcinoma
    Ocanto, Abrahams
    Torres, Lisselott
    Counago, Felipe
    WORLD JOURNAL OF CLINICAL ONCOLOGY, 2024, 15 (06):
  • [48] ANAPLASTIC THYROID-CARCINOMA - IMMUNOHISTOLOGY
    LIVOLSI, VA
    BROOKS, JJ
    ARENDASHDURAND, B
    LABORATORY INVESTIGATION, 1986, 54 (01) : A37 - A37
  • [49] Modeling Anaplastic Thyroid Carcinoma in the Mouse
    Champa, Devora
    Di Cristofano, Antonio
    HORMONES & CANCER, 2015, 6 (01): : 37 - 44
  • [50] Anaplastic Transformation of Differentiated Thyroid Carcinoma
    Yu, Alice C.
    Han, Albert Y.
    Cronkite, David Alex
    Sajed, Dipti
    St John, Maie A.
    LARYNGOSCOPE, 2023, 133 (02): : 437 - 442